Two Sigma Advisers LP increased its position in shares of agilon health, inc. (NYSE:AGL - Free Report) by 4,393.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 480,800 shares of the company's stock after acquiring an additional 470,100 shares during the period. Two Sigma Advisers LP owned about 0.12% of agilon health worth $914,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of AGL. Ieq Capital LLC purchased a new stake in shares of agilon health during the 4th quarter worth about $26,000. Signaturefd LLC increased its holdings in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares during the last quarter. Humankind Investments LLC bought a new position in agilon health during the fourth quarter valued at approximately $30,000. Raymond James Financial Inc. acquired a new stake in agilon health in the fourth quarter valued at approximately $33,000. Finally, Cerity Partners LLC bought a new stake in agilon health in the fourth quarter worth approximately $34,000.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the stock. Stifel Nicolaus increased their price target on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a research note on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. The Goldman Sachs Group increased their price target on shares of agilon health from $2.50 to $5.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. Needham & Company LLC restated a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Finally, Cowen restated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $4.79.
View Our Latest Analysis on agilon health
agilon health Trading Down 4.3%
NYSE:AGL traded down $0.09 during trading hours on Thursday, hitting $2.10. The stock had a trading volume of 2,890,730 shares, compared to its average volume of 4,978,550. The company has a market cap of $867.64 million, a price-to-earnings ratio of -2.23 and a beta of 0.14. agilon health, inc. has a one year low of $1.50 and a one year high of $7.73. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business's 50 day moving average is $3.60 and its 200-day moving average is $3.19.
agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business's quarterly revenue was down 4.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.02) earnings per share. Sell-side analysts anticipate that agilon health, inc. will post -0.59 EPS for the current fiscal year.
About agilon health
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.